![PRD_000899 PRD_000899](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000899.svg) | PRD_000899 | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-8-(2-METHYLPROPYL)-15-(3-[(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | Formula: | C53 H67 N7 O11 S | Definition date: | 2013-01-16 | Last modified: | 2013-06-03 |
|
![PRD_000901 PRD_000901](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000901.svg) | PRD_000901 | Name: | thiomuracin A derivative | Formula: | C53 H54 N13 O9 S6 | Definition date: | 2012-12-26 | Last modified: | 2023-11-03 |
|
![PRD_000958 PRD_000958](https://data.pdbj.org/pdbjplus/data/cc/svg/HUD.svg) | PRD_000958 | Name: | tert-butyl {(2S)-1-[(1R,2S,5S)-2-{[(2S,3R)-4-amino-1-cyclopropyl-3-hydroxy-4-oxobutan-2-yl]carbamoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | Formula: | C26 H44 N4 O6 | Definition date: | 2012-12-26 | Last modified: | 2012-12-26 |
|
![PRD_000893 PRD_000893](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000893.svg) | PRD_000893 | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-15-(3-[METHYL(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-8-(2-METHYLPROPYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | Formula: | C54 H69 N7 O11 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000001 PRD_000001](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000001.svg) | PRD_000001 | Name: | Actinomycin D | Formula: | C62 H86 N12 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000006 PRD_000006](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000006.svg) | PRD_000006 | Name: | 8-Fluoro-Actinomycin D | Formula: | C62 H85 F N12 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXF)
THE CHROMOPHORE PXF IS A MODIFIED PXZ WITH
C-F REPLACING C-H IN POSITION 8 OF THE
PHENOXAZONE RING. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000007 PRD_000007](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000007.svg) | PRD_000007 | Name: | Actinomycin X2 | Formula: | C62 H84 N12 O17 | Description: | ACTINOMYCIN X2 CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000009 PRD_000009](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000009.svg) | PRD_000009 | Name: | Actinomycin Z3 | Formula: | C62 H83 Cl N12 O18 | Description: | ACTINOMYCIN Z3 CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000010 PRD_000010](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000010.svg) | PRD_000010 | Name: | 7-AminoActinomycin | Formula: | C62 H87 N13 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PX1)
THE CHROMOPHORE PX1 IS A MODIFIED PXZ
WITH C-NH2 REPLACING C-H IN POSITION 7 OF THE
PHENOXAZONE RING. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000011 PRD_000011](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000011.svg) | PRD_000011 | Name: | N8-Actinomycin D | Formula: | C61 H85 N13 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXA)
THE CHROMOPHORE PXA IS A MODIFIED PXZ WITH
N REPLACING C-H IN POSITION 8 OF THE
PHENOXAZONE RING. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000020 PRD_000020](https://data.pdbj.org/pdbjplus/data/cc/svg/0G6.svg) | PRD_000020 | Name: | D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide | Formula: | C21 H34 Cl N6 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000900 PRD_000900](https://data.pdbj.org/pdbjplus/data/cc/svg/TIF.svg) | PRD_000900 | Name: | N-(benzylsulfonyl)-D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | Formula: | C26 H35 N5 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000021 PRD_000021](https://data.pdbj.org/pdbjplus/data/cc/svg/0G7.svg) | PRD_000021 | Name: | D-phenylalanyl-N-[(3S)-6-carbamimidamido-1-chloro-2-oxohexan-3-yl]-L-prolinamide | Formula: | C21 H31 Cl N6 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000102 PRD_000102](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000102.svg) | PRD_000102 | Name: | CYCLIC HEXAPEPTIDE RR(NAL)(NAL)RF | Formula: | C53 H70 N15 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000103 PRD_000103](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000103.svg) | PRD_000103 | Name: | CYCLIC HEXAPEPTIDE KKWWKF | Formula: | C49 H68 N11 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000104 PRD_000104](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000104.svg) | PRD_000104 | Name: | CYCLIC HEXAPEPTIDE RRYYRF | Formula: | C45 H66 N15 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000105 PRD_000105](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000105.svg) | PRD_000105 | Name: | CYCLIC HEXAPEPTIDE CYC-(RRWWRF) | Formula: | C49 H68 N17 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000910 PRD_000910](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000910.svg) | PRD_000910 | Name: | B4Z inhibitor | Formula: | C24 H44 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000106 PRD_000106](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000106.svg) | PRD_000106 | Name: | BOC-(D-NLE-L-NLE)4-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | Formula: | C79 H146 N12 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000911 PRD_000911](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000911.svg) | PRD_000911 | Name: | C4Z inhibitor | Formula: | C27 H42 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000107 PRD_000107](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000107.svg) | PRD_000107 | Name: | H-(L-TYR-D-TYR)4-LYS-OH | Formula: | C78 H87 N10 O18 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000912 PRD_000912](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000912.svg) | PRD_000912 | Name: | C6Z inhibitor | Formula: | C34 H54 N8 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000108 PRD_000108](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000108.svg) | PRD_000108 | Name: | HCO-(D-NLE-L-NLE)3-D-MENLE-L-NLE-D-NLE-L-NLE-OME | Formula: | C63 H116 N10 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000913 PRD_000913](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000913.svg) | PRD_000913 | Name: | M4Z inhibitor | Formula: | C24 H39 N7 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000109 PRD_000109](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000109.svg) | PRD_000109 | Name: | BOC-L-NLE-(D-NLE-L-NLE)5-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | Formula: | C96 H177 N15 O18 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|